Innovate Biopharmaceuticals (INNT) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free INNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - April 26 at 11:47 PMCNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Present at the LSX World Congress 2024finanznachrichten.de - April 23 at 10:45 AMSystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officerfinance.yahoo.com - April 22 at 9:23 AMInnovate Change - best online casinos review by the experts 2024msn.com - April 19 at 8:33 AMOcular Therapeutix, Inc.: Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathyfinanznachrichten.de - April 18 at 10:16 AMThird Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Sharesfinance.yahoo.com - April 15 at 7:13 PMAmerican Thoracic Society Selects Vasomune Therapeutics, Inc., to Present the AV-001 Development Update at the 2024 Respiratory Innovation Summitfinance.yahoo.com - April 15 at 8:58 AMUniversity of Phoenix Office of Educational Equity Leadership Presents at 2024 OLC Innovate Conferencetmcnet.com - April 12 at 9:52 AMMonopar Therapeutics Inc.: Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patientsfinanznachrichten.de - April 10 at 11:58 AMIN8bio, Inc: IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024finanznachrichten.de - April 10 at 6:58 AMNIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projectsfinance.yahoo.com - April 9 at 5:52 PMSynaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analyticsstockhouse.com - April 9 at 12:52 PMSyncromune® Inc. Presents Positive Results from SYNC-T™ SV-102 Phase 1 Trial at AACR Annual Meeting 2024tmcnet.com - April 9 at 2:50 AMCadenza Bio, Inc. Appoints Michael A. Panzara, MD, MPH, to its Board of Directorsfinance.yahoo.com - April 4 at 2:09 AMSAB Biotherapeutics, Inc.: SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Resultsfinanznachrichten.de - March 29 at 8:26 AMMonopar Therapeutics Inc.: Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developmentsfinanznachrichten.de - March 28 at 11:12 AMXtalPi Inc.: XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024finanznachrichten.de - March 28 at 12:02 AMCognition Therapeutics, Inc.: Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 26 at 9:08 AMAptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needsfinance.yahoo.com - March 25 at 11:07 PMJanux Therapeutics: A Strong Buy on Innovative Cancer Therapies and Solid Financialsmarkets.businessinsider.com - March 20 at 10:48 PMTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Update on Clinical Programsfinanznachrichten.de - March 20 at 5:48 PMBuy Rating Endorsed for Azitra Inc. on Strong Pipeline and Financial Stabilitymarkets.businessinsider.com - March 20 at 5:48 PMThe problems and promise within Syracuse’s innovation economymsn.com - March 20 at 5:48 PMAlpine Immune Sciences Inc (ALPN) Reports Full Year 2023 Financial Resultsfinance.yahoo.com - March 18 at 6:24 PMClearside Biomedical, Inc.: Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officerfinanznachrichten.de - March 18 at 1:24 PMIN8bio, Inc: IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - March 15 at 11:21 PMJanOne Inc.: JanOne Regains Compliance with Nasdaq's Listing Requirementsfinanznachrichten.de - March 15 at 1:20 PMAkebia Therapeutics, Inc.: Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - March 15 at 8:19 AMEntrada Therapeutics Inc (TRDA) Reports Solid Financial Position and Advancements in Clinical Trialsfinance.yahoo.com - March 15 at 8:19 AMChina’s Drug Stocks Surge on Innovative Drug Support Speculationbloomberg.com - March 14 at 7:14 PMChina Pharma Stocks Surge on Innovative Drug Support Speculationfinance.yahoo.com - March 14 at 2:14 PMPluri Inc.: Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturingfinanznachrichten.de - March 14 at 9:07 AMAtossa Therapeutics, Inc.: Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directorsfinanznachrichten.de - March 12 at 10:38 AMCytomX Therapeutics Inc (CTMX) Reports 2023 Financial Results and Provides Pipeline Updatefinance.yahoo.com - March 11 at 6:41 PMFSD Pharma Inc.: FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzdfinanznachrichten.de - March 11 at 8:40 AMMacroGenics, Inc.: MacroGenics Provides Update on Corporate Progress and 2023 Financial Resultsfinanznachrichten.de - March 8 at 6:05 PMInsider Sell: SR. VICE PRESIDENT & CFO John Kuch Sells 4,474 Shares of Xencor Inc (XNCR)finance.yahoo.com - March 8 at 6:05 PMRezolute, Inc.: Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)finanznachrichten.de - March 7 at 3:41 AMMonopar Therapeutics Inc.: Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Programfinanznachrichten.de - March 5 at 1:45 PMNuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlightsfinance.yahoo.com - March 5 at 8:44 AMVeru Inc.: Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Qfinanznachrichten.de - February 28 at 10:30 AMPushing Boundaries: Tanvex CDMO's Trailblazing Innovation in Biomanufacturingmarkets.businessinsider.com - February 28 at 10:30 AMWork begins on Kenosha's $24M innovation center on former Chrysler sitebizjournals.com - February 27 at 11:45 PMAlexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisistmcnet.com - February 27 at 8:44 AMMonopar Therapeutics Inc.: Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trialfinanznachrichten.de - February 27 at 8:44 AMBuy Rating Affirmed for Alto Neuroscience on Innovative Precision Psychiatry and Promising Drug Candidatesmarkets.businessinsider.com - February 27 at 8:44 AMPTC Therapeutics, Inc.: PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - February 23 at 8:12 AMDecoding Pfizer Inc (PFE): A Strategic SWOT Insightfinance.yahoo.com - February 23 at 8:12 AMDecoding Karuna Therapeutics Inc (KRTX): A Strategic SWOT Insightfinance.yahoo.com - February 23 at 2:21 AM€7m investment for MTU's Cork Cyber Innovate initiativemsn.com - February 22 at 9:20 PM Get Innovate Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> INNT Media Mentions By Week INNT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INNT News Sentiment▼0.000.32▲Average Medical News Sentiment INNT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INNT Articles This Week▼34▲INNT Articles Average Week Get Innovate Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NOVN News Today KLDO News Today HGEN News Today BRSH News Today CNTX News Today GRFS News Today LVTX News Today MYNZ News Today NLSP News Today PHVS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INNT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovate Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
